Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Diphosphonates”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,513 records · Page 84Linked to original sources

Paget's disease of bone.

Paget's disease is a relatively common bone disease. This review aims to present reasonable treatment recommendations with enough background to understand them. To accomplish this end, some aspects of basic bone cell biology, biochemistry, and pathology are presented, as are speculations about possible causes of this disease. Treatment of Paget's disease will be considered in three sections. The first two sections will review treatment with calcitonin and diphosphonates, respectively. These sections briefly will consider the mechanism of action of the drugs, review in detail clinical studies of drug effectiveness, and summarize the advantages and disadvantages of each drug. The third section details specific treatment recommendations for each of the six clinical settings in which treatment of Paget's disease is justified.

Calcitonin↗

Clinical use of bisphosphonates.

The bisphosphonates (formerly known as diphosphonates) constitute a recently developed class of drugs for use in a variety of diseases of bone and calcium metabolism. Developed in the past three decades, only a few compounds of this large family of drugs are now commercially available for various therapeutic indications that vary broadly, from country to country. The clinical use of bisphosphonates is based on their ability to inhibit bone resorption. Thus, their main indications concern diseases with high bone remodeling, such as Paget's disease of bone, osteoporosis, metastatic bone diseases, and malignant and nonmalignant hypercalcemia. Their other main action is to inhibit bone formation; the ratio of inhibition of bone resorption to inhibition of bone formation varies according to the compounds. This ratio is less favorable for the first available bisphosphonates, such as etidronate. New bisphosphonates are more and more potent and possess a safer ratio. With their increasing power, there could be some risk of freezing bone remodeling, but so far this fearful complication has not yet been observed.

Bone Diseases, Metabolic↗

Localization of bone-seeking agent within a desmoid tumor.

This is a case report of a patient who had a desmoid tumor which localized 99mTc-diphosphonate. The mechanism for this localization was felt to be the affinity of the bone agent for the immature proliferating collagen in this tumor.

Adult↗

Radiotracer imaging in a case of diffuse skeletal hemangiomatosis.

The hospital course of a patient with diffuse skeletal hemangiomatosis is presented with reference to the role of radionuclide imaging procedures in the diagnosis and evaluation of this disorder. In addition to static scans of liver, bone, and bone marrow, flow studies using Tc-99m-sulfur colloid and methylene diphosphonate (MDP) were performed.

Adult↗

Tc-99m MDP and indium-111 chloride scintigraphy in skeletal tuberculosis.

A case of diffuse osseous tuberculosis with changes on skeletal Tc-99m methylene diphosphonate (MDP) and indium-111 chloride scintigraphy is presented. Only two other cases of bone scan findings in osseous tuberculosis (TB) were reported in the literature and both show patterns similar to diffuse metastatic disease. In addition, the demonstration of corresponding areas of decreased tracer activity on indium-111 bone marrow scintigraphy is a finding that has not been previously reported for skeletal tuberculosis.

Adult↗

Bone scintigraphy in slipped capital femoral epiphysis.

Tc-99m diphosphonate bone scans were performed on 11 children with slipped capital femoral epiphysis. On pinhole hip images, seven hips in seven patients had increased radionuclide uptake in the physis and adjacent proximal femoral metaphysis where the slip had occurred. Three hips in three patients had decreased radionuclide uptake in the femoral head on the side of the slipped epiphysis, indicating compromise of the femoral head blood supply. Three or more months following internal fixation, three children had scintigraphy that showed loss of the usual focal uptake in the physis and adjacent proximal femoral metaphysis. Bone scintigraphy in pediatric patients with slipped capital femoral epiphysis is valuable in defining the metabolic status of the femoral head. Absence of radiopharmaceutical uptake in the affected femoral head indicates that the femoral head is at risk for development of radiographic changes associated with aseptic necrosis.

Child↗

A comparison between whole body scans made at two hours and three hours after intravenous injection of Tc-99m HDP as to image quality and lesion detectability.

Bone scans of 35 patients were evaluated as to the quality and the number of bone lesions that could be detected at studies 2 hours and 3 hours after injection of Tc-99m HDP. It was found that 2 hour bone scans are of high "cosmetic" and diagnostic quality and that all lesions present at 3 hour scans are well visualized at 2 hours. These features are among the major advantages of the use of Tc-99m HDP over other diphosphonates.

Adult↗

Scintigraphic detection of prosthetic joint and soft tissue sepsis secondary to tuberculosis.

In a 40-year-old Hispanic woman with pain and swelling in the left knee with a prosthesis, the combination of Ga-67 citrate and Tc-99m methylene diphosphonate (MDP) scans was used to indicate that there was a septic prosthetic joint. At surgery, the joint was infected and a foreign body was found. Cultures positive for tuberculosis were found also. The presence of an incongruent Ga-67 and Tc-99m (MDP) scan pattern suggests infection of the prosthetic joint, as in the following case.

Adult↗

Bone scintigraphic demonstration of synovial chondromatosis.

Markedly increased periarticular Tc-99m diphosphonate uptake around the knee is described in a patient found to have synovial chondromatosis. The pathophysiology and possible causes of bone tracer uptake in this cartilaginous disorder are discussed.

Cartilage Diseases↗

Tc-99m HMPAO labeled leukocytes superior to bone scan in the detection of osteomyelitis in children.

Seven children (aged 7 to 16 years) with confirmed osteomyelitis underwent imaging with Tc-99m HMPAO labeled leukocytes and with Tc-99m diphosphonates. The patients were scanned at 1/2 hour and at 3 hours. The scans were evaluated visually, and the lesion-to-normal bone ratios were quantitated. All the lesions on leukocyte scans and six out of seven lesions in bone scans were readily detectable 1/2 hour after injection of the radiopharmaceutical, but 3 hours is the better imaging time. In quantitative analysis, the lesion-to-normal bone ratio increased with leukocytes significantly higher than with the bone scans (P less than 0.05). When the scintigraphic findings were compared with surgical and radiologic results, the leukocyte images detected and localized lesions better than the bone scans. According to these preliminary results, Tc-99m HMPAO labeled leukocytes seem to offer a rapid and accurate method for detecting bone infections.

Adolescent↗

The prognostic value and significance of serial bone scintigraphy in Legg-Calvé-Perthes disease.

We reviewed 44 consecutive patients treated for Legg-Calvé-Perthes disease who underwent serial technetium 99m diphosphonate bone scintigraphy. The average follow-up was 4.4 years. The bone-scintigraphy classification characterizes the A pathway by early lateral column formation not seen in the B pathway. Pathway A had 20 hips. The average age at presentation was 6.1 years. At last follow-up, this group had an average Mose classification of 1.2 and Catterall score of 2.4, without any patient having "head-at-risk" signs or requiring operative treatment. Pathway B had 20 hips. The average age at presentation was 5.8 years. At last follow-up, this group had an average Mose classification of 5.2, a Catterall score of 3.5, and 18 patients had head-at-risk signs, with 11 requiring operative treatment. Our bone-scintigraphy classification preceded the radiographic head-at-risk signs by an average of 3 months, allowing earlier treatment and correlated with subsequent femoral head involvement.

Child↗

Radionuclide bone scanning in the diagnosis and management of condylar hyperplasia.

Four patients with maxillo-mandibular facial dysharmony and four controls were evaluated by 99Tcm-MDP (methyl diphosphonate) scintiscanning. The scintiscans in all patients with dysharmony showed positive uptake of the tracer indicating the increased degree of activity in the condylar region of the mandible. The significance of this is discussed.

Adolescent↗

Quantitative radionuclide scanning in metabolic bone disease.

A simple method of quantifying skeletal uptake of 99Tcm-methylene diphosphonate, using a rectilinear scanner and a simultaneously image standard, is described. The pattern of quantified uptake in ten regions of the skeleton, the sacro-iliac joints and kidneys in 57 controls and 54 patients with various metabolic bone disease is presented. This method distinguishes patients with primary hyperparathyroidism and osteomalacia from controls with a sensitivity adequate for clinical purposes. In primary hyperparathyroidism the increased skull uptake of tracer correlated well with levels of serum alkaline phosphatase, plasma parathyroid hormone, urinary hydroxyproline excretion and the degree of intracortical resorption in the metacarpal bones. The skull uptake in oestoporosis was normal or moderately elevated and correlated well with bone mass density measurements of the radius. Patients with osteomalacia also showed the greatest increase in tracer uptake in the skull. Patients with thyrotoxicosis differed from most other patients by showing moderately increased uptake in shafts of long bones. We propose our method of quantitative bone uptake as a useful noninvasive test to detect metabolic bone disease and to monitor responses to therapy of bone disease.

Adolescent↗

Tracer flows and 'difficult' organs.

This paper describes a method for measuring tracer kinetics in organs which are larger than the field of view of a gamma camera, by performing initial dynamic studies on part of that organ, followed by a later study to determine the tracer content of the entire organ. Information is transferred from the measured data to 'absolute values' by means of a calculated intermediate number which is called the 'MTBE' (mean time in blood, equivalent). Initial testing of the technique with methylene diphosphonate (MDP) bone studies produced tracer flow rates of 0.000366 s-1 into bone and 0.001525 s-1 into interstitial fluid in patients with no known bone disease. Patients with active Paget's disease of bone had higher bone inflow rates, and showed some improvement following therapy with either editronate or pamidronate. The method has the potential to be applied to other situations, particularly SPET, using SPET to calculate tracer content and converting the results to flow rates using the formula: Inflow rate = Content/MTBE.

Bone and Bones↗

Pentavalent 99Tcm-DMSA imaging in patients with bone metastases.

Pentavalent 99Tcm-dimercaptosuccinic acid (99Tcm-(V)DMSA) has an established role in imaging medullary thyroid carcinoma. There have been case reports of uptake in bone metastases. Our aims were to compare 99Tcm-(V)DMSA with 99Tcm-hydroxymethylene diphosphonate (99Tcm-HDP) in bone metastases, to assess its value in imaging of bone metastases, and to assess the prospects of the beta-emitting analogues 186/188Re-(V)DMSA as palliative agents for painful bone metastases. Ten patients confirmed by a 99Tcm-HDP bone scan to have bone metastases secondary to carcinoma of the prostate, lung or breast were injected with 99Tcm-(V)DMSA (600 MBq). Whole-body scans acquired at 3 and 24 h were compared with the 99Tcm-HDP bone scans. 99Tcm-(V)DMSA showed high soft tissue background, kidney retention and avid uptake in most bone metastases: 86% of bone lesions identified on bone scans were detected with 99Tcm-(V)DMSA. The lesion-to-normal ratios were comparable to or lower than those for 99Tcm-HDP at 3 h, but increased by 24 h. Instances of abnormal uptake in liver, primary lung tumour, lymph nodes and pleural effusion were observed. We conclude that 99Tcm-(V)DMSA is a tracer for bone metastases (with lower sensitivity than 99Tcm-HDP) and soft tissue tumours. If 186/188Re-(V)DMSA behave similarly, they may find use in therapy for soft tissue tumours and bony metastases.

Bone Neoplasms↗

Hydration does not influence the image quality in bone scintigraphy: an investigation using 99Tcm-HDP.

We investigated the possibility that the increased diuresis caused by hydration leads to enhanced renal excretion of radiotracer and thereby increases the target-to-background activity ratio and improves the image quality in bone scintigraphy. The study was carried out using paired comparisons in 10 healthy volunteers. Whole-body antero-posterior and postero-anterior acquisitions were obtained for 4 h after the administration of 99Tcm-hydroxymethylene diphosphonate with and without hydration. The bone-to-soft tissue activity ratio was semi-quantified by comparing regions of interest acquired from geometrical means of the acquisitions. Hydration was performed by slowly drinking 1.5 litres of water after administration of the tracer. Hydration induced a slight enhancement of excretion of the activity, but it had no effect on the bone-to-soft tissue activity ratio, nor did it influence image quality. We conclude that hydration could be avoided when it is cumbersome for the patient. However, as hydration reduces the radiation dose to the urinary bladder wall, which is the critical organ, hydration should be maintained in younger patients.

Adult↗